Immunome Stock News

Renaissance Technologies LLC purchased a new position in shares of Immunome, Inc. (NASDAQ:IMNM) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 20,400 shares of the companys stock, valued at approximately $353,000. A number of other hedge funds have also recently bought and sold shares of the []

Geode Capital Management LLC reduced its stake in shares of Immunome, Inc. (NASDAQ:IMNM) by 19.9% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 39,529 shares of the companys stock after selling 9,802 shares during the quarter. Geode Capital Management LLC owned approximately []

EXTON, Pa.--(BUSINESS WIRE)--Immunome to Present Preclinical Data on Anti IL-38 at AACR's NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

EXTON, Pa.--(BUSINESS WIRE)--Immunome to Present at the Cantor Global Healthcare Conference

EXTON, Pa.--(BUSINESS WIRE)--Immunome to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit

Life Clips (LCLP) stock is falling on Tuesday following an update from the battery company about its recent business announcements. The post LCLP Stock: 10 Reasons Why Penny Stock Battery Maker Life C

IMNM stock is having a great day today. The company is preparing to move forward with expedited testing for its delta variant treatment.

Immunome Inc (NASDAQ: IMNM) has announced that its three-antibody cocktail (IMM-BCP-01) has demonstrated potent neutralizing activity against COVI-19 Delta variant in pre-clinical pseudovirus testi

The stock price of Immunome Inc (NASDAQ: IMNM) increased by over 35% pre-market. This is why it happened.

Immunome Inc (NASDAQ: IMNM) has secured additional funding of $4.3 million from the Department of Defense (DoD) for the development of an antibody cocktail (IMM-BCP-01) to combat SARS-CoV-2 and its

EXTON, Pa.--(BUSINESS WIRE)--Immunome Reports First Quarter 2021 Financial Results

The stock price of Immunome Inc (NASDAQ: IMNM) increased by over 10% pre-market. This is why it happened.

In addition to encouraging preclinical data from the COVID-19 antibody cocktail announced today, Immunome Inc (NASDAQ: IMNM) has entered into a private placement agreement of approximately $27

Immunome Inc (NASDAQ: IMNM) has announced antibody selection for its IMM-BCP-01 antibody cocktail and shared preclinical data showing that IMM-BCP-01 is effective against the current SARS-CoV-2 an